Effect of the nature of the polymer and of the process of drug release (diffusion or erosion) for oral dosage forms

被引:12
作者
Aïnaoui, A [1 ]
Vergnaud, JM [1 ]
机构
[1] Univ St Etienne, Fac Sci, Lab Mat & Chem Engn, F-42023 St Etienne, France
来源
COMPUTATIONAL AND THEORETICAL POLYMER SCIENCE | 2000年 / 10卷 / 05期
关键词
polymer; oral dosage form; diffusion; erosion; shape; drug delivery; controlled release;
D O I
10.1016/S1089-3156(00)00004-0
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Conventional oral dosage forms with immediate release are associated with plasma drug levels alternating between high peaks and low troughs lending to harmful side effects. These side effects are reduced and the therapy is optimized by using oral dosage forms with controlled release. Usually these dosage forms consist of devices where the drug is dispersed through a biocompatible polymer, which plays the role of a matrix, and the polymer plays the major role for controlling the drug release along the gastrointestinal tract. Depending on the nature of the polymer, the process of drug release is different and the two extreme cases are considered: the one with stable polymers where the drug release is controlled by diffusion with the more simple case of constant diffusivity; the other with erodible polymers with a constant rate of erosion. As the gastrointestinal transit time is finite, the radius of spherical dosage forms is evaluated such that the time of drug delivery is 24 h. Various shapes are also considered with the same polymer and the same diffusivity or rate of erosion, by keeping the same volume and mass of drug for these dosage forms. Following these studies, the plasma drug level is also assessed for these two types of dosage forms. Some results of interest are obtained: for each type of polymer, the shape given to the dosage form exhibits some interest for the kinetics of drug release; the type of polymer is of prime importance, and erodible polymers are associated with a more constant plasma drug level. Thus these results take stock of the question of drug release by considering the properties of the polymer, whether it is stable with its diffusivity or it is erodible with its rate of erosion. Finally this knowledge makes possible the evaluation of the dimensions of dosage forms necessary for a given time of drug delivery and a given therapy. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:383 / 390
页数:8
相关论文
共 41 条
[31]   Assessment of antibiotic levels in lung tissue with erosion-controlled dosage forms [J].
Saidna, M ;
Ouriemchi, EM ;
Vergnaud, JM .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1997, 22 (03) :237-243
[32]   Calculation of the antibiotic level in the lung tissue and bronchial secretion with an oral controlled-release dosage form [J].
Saïdna M. ;
Ouriemchi E.M. ;
Vergnaud J.M. .
InflammoPharmacology, 1998, 6 (4) :321-337
[33]   Calculation of the dimensions of drug-polymer devices based on diffusion parameters [J].
Siepmann, J ;
Ainaoui, A ;
Vergnaud, JM ;
Bodmeier, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (07) :827-832
[34]   PERSPECTIVES OF INVITRO DISSOLUTION TESTS IN ESTABLISHING INVIVO INVITRO CORRELATIONS [J].
SIEWERT, M .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1993, 18 (01) :7-18
[35]   INVITRO INVIVO CORRELATIONS IN BIOPHARMACEUTICS - SCIENTIFIC AND REGULATORY IMPLICATIONS [J].
SKELLY, JP ;
SHIU, GF .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1993, 18 (01) :121-129
[36]   REPORT OF THE WORKSHOP ON CONTROLLED-RELEASE DOSAGE FORMS - ISSUES AND CONTROVERSIES [J].
SKELLY, JP ;
BARR, WH ;
BENET, LZ ;
DOLUISIO, JT ;
GOLDBERG, AH ;
LEVY, G ;
LOWENTHAL, DT ;
ROBINSON, JR ;
SHAH, VP ;
TEMPLE, RJ ;
YACOBI, A .
PHARMACEUTICAL RESEARCH, 1987, 4 (01) :75-77
[37]   REPORT OF THE WORKSHOP ON - INVITRO AND INVIVO TESTING AND CORRELATION FOR ORAL CONTROLLED MODIFIED RELEASE DOSAGE FORMS [J].
SKELLY, JP ;
AMIDON, GL ;
BARR, WH ;
BENET, LZ ;
CARTER, JE ;
ROBINSON, JR ;
SHAH, VP ;
YACOBI, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 63 (02) :83-93
[38]   INVITRO AND INVIVO TESTING AND CORRELATION FOR ORAL CONTROLLED MODIFIED RELEASE DOSAGE FORMS - REPORT OF THE 2ND WORKSHOP HELD DECEMBER 1988, WASHINGTON, DC, USA [J].
SKELLY, JP ;
AMIDON, GL ;
BARR, WH ;
BENET, LZ ;
CARTER, JE ;
ROBINSON, JR ;
SHAH, VP ;
YACOBI, A .
JOURNAL OF CONTROLLED RELEASE, 1990, 14 (01) :95-106
[39]   DRUG RELEASE FROM NON-DISINTEGRATING HYDROPHILIC MATRICES - SODIUM-SALICYLATE AS A MODEL-DRUG [J].
TOUITOU, E ;
DONBROW, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 11 (04) :355-364
[40]  
VERGNAUD JM, 1993, CONTROLLED DRUG RELE, pCH1